Compare QNRX & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNRX | SWVL |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United Arab Emirates |
| Employees | N/A | 284 |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 15.6M |
| IPO Year | 2023 | N/A |
| Metric | QNRX | SWVL |
|---|---|---|
| Price | $8.16 | $1.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.0K | ★ 22.7K |
| Earning Date | 05-12-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $1.32 |
| 52 Week High | $41.80 | $4.99 |
| Indicator | QNRX | SWVL |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 43.14 |
| Support Level | $8.03 | $1.34 |
| Resistance Level | $8.97 | $3.83 |
| Average True Range (ATR) | 0.41 | 0.07 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 47.29 | 33.18 |
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.